This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

HMO To Stand Trial In Las Vegas For Role In Largest Hepatitis C Outbreak In U.S. History

LAS VEGAS , Feb. 19, 2013 /PRNewswire/ -- Health Plan of Nevada will face a Nevada jury for the role of the HMO in the largest outbreak of hepatitis C in U.S. history.

(Photo: http://photos.prnewswire.com/prnh/20130219/LA62190)

The complaint filed in Clark County District Court cites the duty to monitor the effectiveness and safety of the health care providers and clinics required by the HMO for use by its members, and the failure to monitor, as leading to the notification from the Southern Nevada Health District to 50,000 Nevadans that they may have been exposed to hepatitis C or HIV. The complaint also cites billing fraud, changing of records to conceal malpractice and false advertising. 

"The Health Plan of Nevada can not take money from thousands of Nevadans, require them to use clinics such as the Endoscopy Center of Southern Nevada and not look out for their safety. This and other facts about what the HMO knew about the practices of Dr. Desai and the clinics will be exposed in trial," said Robert Eglet, lead trial attorney for the plaintiffs. 

Bonnie Brunson, one of the genetically linked patients identified by the CDC and the Southern Nevada Health District, and husband Carl Brunson, and Helen Meyer, an individual, are named as plaintiffs. 

Opening statements begin February 20, 9am, Regional Justice Center, 200 Lewis Avenue, Las Vegas, 89101 in Department 12D before Judge Timothy Williams. Follow trial updates on twitter: @LVHepCTrial. 

SOURCE SCM

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,630.27 +189.68 1.09%
S&P 500 2,093.25 +25.61 1.24%
NASDAQ 5,089.2060 +49.43 0.98%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs